دورية أكاديمية
Editor's Choice - Outcomes of Cold Stored Saphenous Vein Allografts for Haemodialysis Vascular Access.
| العنوان: | Editor's Choice - Outcomes of Cold Stored Saphenous Vein Allografts for Haemodialysis Vascular Access. |
|---|---|
| المؤلفون: | Cherkaoui R; Department of Vascular and Endovascular Surgery, Nancy University Hospital, University of Lorraine, Vandoeuvre-Les-Nancy, France., Picard E; Department of Vascular and Thoracic Surgery, Nimes University Hospital, Nimes, France., Branchereau P; Department of Vascular and Thoracic Surgery, Nimes University Hospital, Nimes, France., Saba C; Department of Vascular and Endovascular Surgery, Nancy University Hospital, University of Lorraine, Vandoeuvre-Les-Nancy, France., Derycke L; Department of Cardio-Vascular and Vascular Surgery, Hôpital Européen Georges Pompidou, Paris, France., Settembre N; Department of Vascular and Endovascular Surgery, Nancy University Hospital, University of Lorraine, Vandoeuvre-Les-Nancy, France; University of Lorraine, INSERM UMR_S 1116 DCAC, Nancy, France., Malikov S; Department of Vascular and Endovascular Surgery, Nancy University Hospital, University of Lorraine, Vandoeuvre-Les-Nancy, France; University of Lorraine, INSERM UMR_S 1116 DCAC, Nancy, France., Faure EM; Department of Vascular and Thoracic Surgery, Nimes University Hospital, Nimes, France; University of Nimes, UR-UM 103 IMAGINE, Nimes, France. Electronic address: elsa.faure@chu-nimes.fr. |
| المصدر: | European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery [Eur J Vasc Endovasc Surg] 2024 Sep; Vol. 68 (3), pp. 397-404. Date of Electronic Publication: 2024 May 07. |
| نوع المنشور: | Journal Article; Multicenter Study |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier Country of Publication: England NLM ID: 9512728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2165 (Electronic) Linking ISSN: 10785884 NLM ISO Abbreviation: Eur J Vasc Endovasc Surg Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2002-: London : Elsevier Original Publication: London, UK : W.B. Saunders Co. Ltd., c1995- |
| مواضيع طبية MeSH: | Renal Dialysis* , Saphenous Vein*/transplantation , Vascular Patency* , Arteriovenous Shunt, Surgical*/adverse effects , Arteriovenous Shunt, Surgical*/methods, Humans ; Female ; Male ; Retrospective Studies ; Aged ; Middle Aged ; Treatment Outcome ; Allografts ; Graft Occlusion, Vascular/etiology ; Graft Occlusion, Vascular/epidemiology ; Graft Occlusion, Vascular/physiopathology ; Aged, 80 and over ; Risk Factors ; Time Factors ; Cryopreservation ; Blood Vessel Prosthesis Implantation/adverse effects ; Blood Vessel Prosthesis Implantation/instrumentation |
| مستخلص: | Objective: The aim of this study was to evaluate the outcomes of cold stored saphenous vein allografts (CSVAs) for haemodialysis vascular access. Methods: A retrospective, two centre study was conducted between January 2016 and December 2020 of all patients who had CSVA placement for haemodialysis vascular access. Primary, primary assisted, and secondary patency were analysed, as well as procedural complications and re-interventions. Results: One hundred and nine patients (n = 55 women) with a mean age of 67.2 ± 13.6 years, with no options for creating an autogenous arteriovenous fistula, were included in the study. At one year, primary, primary assisted, and secondary patency were 37.6%, 59.0%, and 73.3%, respectively; and at two years 19.9%, 42.5%, and 54.9%, respectively. During a mean follow up period of 26 ± 18 months, five patients (4.6%) had an access infection, with no related death. During the follow up period, 32 patients (29.4%) died and 13 patients (11.9%) underwent a kidney transplant. None of these patients showed immunoconversion before transplantation. The cumulative incidence of adverse events by the Fine-Gray method was calculated. Considering competing risks (death and renal transplantation), 9.2% of patients lost their vascular access at one year and 18% at two years. Moreover, 57.8% patients had stenosis, mainly on the outflow (45.9%), and 49.5% had thrombosis. Conclusion: With a comparable patency rate associated with a low infection rate, CSVA offers a potential alternative to expanded polytetrafluoroethylene grafts. This creates haemodialysis vascular access when the venous capital is exhausted in patients with reported risk factors for vascular access infection, i.e., insertion in the thigh, advanced age, diabetes mellitus, immunocompromised state, obesity, or revision of an infected prosthetic graft. (Copyright © 2024 European Society for Vascular Surgery. Published by Elsevier B.V. All rights reserved.) |
| فهرسة مساهمة: | Keywords: Allograft; Arteriovenous fistula; Dialysis; Haemodialysis; Risk assessment; Vascular patency |
| تواريخ الأحداث: | Date Created: 20240509 Date Completed: 20240913 Latest Revision: 20240913 |
| رمز التحديث: | 20240914 |
| DOI: | 10.1016/j.ejvs.2024.04.042 |
| PMID: | 38723741 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 1532-2165 |
|---|---|
| DOI: | 10.1016/j.ejvs.2024.04.042 |